relatlimab,nivolumab,sacituzumab,ipilimumab,pembrolizumab
merck,bms,gilead
['neopredict', 'nivo', 'lung', 'neostar', 'lcsm,(-blcsm)', 'relatlimab', ' ipi ']
neopredict-lung with nivo + relatlimab in phii shows feasibility and safety with combo io in the neoadjuvant setting, however, with no additional efficacy results when compared to nivo + ipi in neostar and quite a modest increase in orr with rela. #asco23 #lcsm
Husband, Father.
Medical Oncologist and Researcher focused in Thoracic Oncology.
Views are my own.